Attached files

file filename
EX-8.1 - AIkido Pharma Inc.v219106_ex8-1.htm
EX-99.1 - AIkido Pharma Inc.v219106_ex99-1.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
April 19, 2011

 
 

Spherix Incorporated

(Exact name of registrant as specified in its charter)
 
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
Delaware
0-5576
52-0849320

(Address of principal executive offices)
 
(Zip Code)
6430 Rockledge Drive, Suite 503, Bethesda, Maryland
 
20817

Registrant’s telephone number, including area code
301-897-2540



(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.                                Other Events.

Spherix Incorporated (the “Company”) announced today that its Board of Directors has unanimously approved a reverse stock split of the Company’s common stock effective as of the close of business on May 6, 2011, at a ratio of one (1) new share for each existing ten (10) shares.  In November 2009, the Company’s shareholders provided the Board of Directors authority to effect this reverse stock split.

The reverse stock split will become effective on May 6, 2011, upon the filing of a Certificate of Amendment with the State of Delaware.  A copy of the Certificate of Amendment is attached hereto as Exhibit 8.1.
 
 
1
 
 

 

 
A copy of the Company’s press release announcing the reverse stock split is attached as Exhibit 99.1 hereto.

Section 9 – Financial Statements and Exhibits

Exhibit
 
Number
Description
   
8.1
Certificate of Amendment
   
99.1
Press Release dated April 19, 2011


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Spherix Incorporated
 
(Registrant)
     
 
By:
 
     
 
/s/ Robert L. Clayton
 
Robert L. Clayton, CFO
     
 
Date:
April 19, 2011
 
 
 
 
 
 
 
 
2